Peoria IL 非小细胞肺癌临床试验
21项针对 非小细胞肺癌的研究正在 Peoria及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
招募中2 期
- Illinois CancerCare-Peoria, Peoria
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria
- OSF Saint Francis Medical Center, Peoria
- 以及另外 3 项
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
招募中2/3 期
- OSF Saint Francis Medical Center, Peoria
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
招募中3 期
- Illinois Cancer Care ( Site 7000), Peoria
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
招募中3 期
- Illinois Cancer Care, Peoria
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- Illinois Cancer Care, Peoria
- Illinois CancerCare- Pekin, Pekin · 距离 9 英里
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Illinois CancerCare, P.C., Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Illinois CancerCare, Peoria
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
招募中2 期
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- 以及另外 1 项
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- OSF Saint Francis Medical Center, Peoria
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
招募中1 期
- OSF Health Care, Peoria
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
招募中1 期
- OSF Saint Francis Medical Center, Peoria
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
招募中1 期
- OSF Healthcare System; Saint Francis Medical Center, Peoria
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
招募中1 期
- St. Francis Medical Center (OSF Healthcare), Peoria
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
招募中1 期
- OSF Healthcare Cancer Institute, Peoria
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 距离 9 英里
- Illinois CancerCare-Canton, Canton · 距离 25 英里
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Peoria的其他研究
- 肺癌12 项研究
- 结直肠癌12 项研究
- 前列腺癌9 项研究
- 乳腺癌8 项研究
- 心力衰竭8 项研究
- 胰腺癌7 项研究
- 卵巢癌7 项研究
- 头颈鳞状细胞癌7 项研究
- 转移性癌症7 项研究
- 癌症（所有类型）7 项研究
- 急性髓系白血病6 项研究
- 黑色素瘤6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。